Marksans Pharma Shares Plunge After Weak Quarterly Results

Marksans Pharma's stock price dropped because the company didn't make as much money in the last three months.

Their profits were down because sales were slow in some areas like the UK and Australia.

They also spent more on employees and had some unexpected costs.

However, sales in the US went up because they launched new products there.

The company's total sales increased slightly, but profits decreased.

The company is hopeful that things will get better soon and that sales will pick up again, especially in the US, UK and Australia.

They are also working on making their operations more efficient.